to assess the value and safety of thrombolytic therapy compared to conventional antithrombotic therapy ( aspirin ) in arresting progression in this setting to recurrent ischemic end-points , 25 patients presenting with unstable angina and an electrocardiogram showing subendocardial ischemia were randomized to receive either aspirin 325 mg daily , or urokinase 3 x 10 ( 6 ) u intravenously , over 30 minutes followed by heparin .
C0002965
unstable angina
C0019134
heparin